Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice
about
AE2 Cl-/HCO3- exchanger is required for normal cAMP-stimulated anion secretion in murine proximal colonCLIC5 mutant mice are resistant to diet-induced obesity and exhibit gastric hemorrhaging and increased susceptibility to torporMultiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.Loss of SLC9A3 decreases CFTR protein and causes obstructed azoospermia in mice.Functional vacuolar ATPase (V-ATPase) proton pumps traffic to the enterocyte brush border membrane and require CFTR.Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.The epithelial sodium/proton exchanger, NHE3, is necessary for renal and intestinal calcium (re)absorptionRecent advances in small bowel diseases: Part II.Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.Status of fluid and electrolyte absorption in cystic fibrosis.Differential expression of pancreatic protein and chemosensing receptor mRNAs in NKCC1-null intestineThe cystic fibrosis intestine.A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint.Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3.Intestinal brush-border Na+/H+ exchanger-3 drives H+-coupled iron absorption in the mouse.Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.Renal tubular NHE3 is required in the maintenance of water and sodium chloride homeostasis.Reduced NHE3 activity results in congenital diarrhea and can predispose to inflammatory bowel disease.SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretionToll-like receptor-4 genotype influences the survival of cystic fibrosis miceRecent advances in developing therapeutics for cystic fibrosis
P2860
Q24597250-41021591-3D8F-4E3F-ADA9-280D860A8411Q28512655-C232F312-E05E-4276-8D83-9B3F36C2E087Q30426239-9A131664-21F1-4F45-9553-1E6D5F4EBFF2Q33585358-A7F4641A-9C9D-4501-8521-D218B90CB45BQ33944537-6B4D59C3-FBA0-4CBF-A151-71CC601C31C7Q34205956-19454CB4-2E53-44EE-A881-BD6084E4A9F0Q35900618-8212370B-123F-47EC-A331-68145C720CE1Q36093336-2A4CE228-3750-40AC-B03B-B2233D683317Q36108378-0BCB40AC-BABE-470D-800D-791DBDE05DA1Q36488263-8D5426BF-538C-479B-A315-D868C6D062FCQ36578901-E9CFEC39-3653-4C5E-9734-FDDCC0982C5AQ37122355-A65ECB42-55FE-4539-8D02-3C2AC297DD66Q38873028-ECC7DCC7-0DF3-4353-9C10-E22F9C9AFC80Q38979089-D261F14B-AB51-4137-A973-11AE28DC6ED0Q39622458-0CDEA896-2734-4438-8A1F-521EDBF09409Q44314873-4D97182D-FFC9-4B7C-ADBC-2120E739EEC9Q46774064-4A8C6AC9-B045-44FD-9C83-B5FF020F602FQ48177314-A5253C58-2DD1-4965-95D2-577122DEDFCCQ56535583-F944D84E-4EF1-4C7C-B032-43DAF12CEB2FQ57124971-8A7CB2A3-9A07-43DA-AAE5-B5E0489408BEQ57172314-D11F6041-7604-4D74-AEBE-CD4A388CEF13
P2860
Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduced NHE3-mediated Na+ abso ...... ctions in cystic fibrosis mice
@en
Reduced NHE3-mediated Na+ abso ...... tions in cystic fibrosis mice.
@nl
type
label
Reduced NHE3-mediated Na+ abso ...... ctions in cystic fibrosis mice
@en
Reduced NHE3-mediated Na+ abso ...... tions in cystic fibrosis mice.
@nl
prefLabel
Reduced NHE3-mediated Na+ abso ...... ctions in cystic fibrosis mice
@en
Reduced NHE3-mediated Na+ abso ...... tions in cystic fibrosis mice.
@nl
P2093
P2860
P356
P1476
Reduced NHE3-mediated Na+ abso ...... ctions in cystic fibrosis mice
@en
P2093
Emily M Bradford
Gary E Shull
Lane L Clarke
Lara R Gawenis
P2860
P304
P356
10.1152/AJPGI.90520.2008
P577
2009-01-22T00:00:00Z